Literature DB >> 34217594

Current status and relevance of single nucleotide polymorphisms in IL-6-/IL-12-type cytokine receptors.

Jürgen Scheller1, Anna Berg2, Jens M Moll2, Doreen M Floss2, Christopher Jungesblut3.   

Abstract

Cytokines control immune related events and are critically involved in a plethora of patho-physiological processes including autoimmunity and cancer development. In rare cases, single nucleotide polymorphisms (SNPs) or single nucleotide variations (SNVs) in cytokine receptors eventually cause detrimental ligand-independent, constitutive activation of signal transduction. Most SNPs have, however, no or only marginal influences on gene expression, protein stability, localization and function and thereby only slightly affecting pathogenesis probability. The SNP database (dbSNP) is an archive for a broad collection of polymorphisms in which SNPs are categorized and marked with a locus accession number "reference SNP" (rs). Here, we engineered an algorithm to directly align dbSNP information to DNA and protein sequence information to clearly illustrate a genetic SNP landscape exemplified for all tall cytokine receptors of the IL-6/IL-12 family, including IL-23R, IL-12Rβ1, IL-12Rβ2, gp130, LIFR, OSMR and WSX-1. This information was complemented by a comprehensive literature summary and structural insights of relevant disease-causing SNPs in cytokine/cytokine receptor interfaces. In summary, we present a general strategy with potential to apply to other cytokine receptor networks.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cytokine; Gp130; IL-12; IL-12Rβ1; IL-12Rβ2; IL-23; IL-23R; IL-27; IL-6; LIF; LIFR; OSM; OSMR; Receptor; SNP; SNV

Mesh:

Substances:

Year:  2021        PMID: 34217594     DOI: 10.1016/j.cyto.2021.155550

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  3 in total

1.  Exclusive inhibition of IL-6 trans-signaling by soluble gp130FlyRFc.

Authors:  Anna F Berg; Julia Ettich; Hendrik T Weitz; Matthias Krusche; Doreen M Floss; Jürgen Scheller; Jens M Moll
Journal:  Cytokine X       Date:  2021-11-29

Review 2.  Jak Inhibitors for Treatment of Autoimmune Diseases: Lessons from Systemic Sclerosis and Systemic Lupus Erythematosus.

Authors:  Przemysław Kotyla; Olga Gumkowska-Sroka; Bartosz Wnuk; Kacper Kotyla
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-28

3.  New-Generation Heterocyclic Bis-Pentamethinium Salts as Potential Cytostatic Drugs with Dual IL-6R and Mitochondria-Targeting Activity.

Authors:  Veronika Talianová; Zdeněk Kejík; Robert Kaplánek; Kateřina Veselá; Nikita Abramenko; Lukáš Lacina; Karolína Strnadová; Barbora Dvořánková; Pavel Martásek; Michal Masařík; Magdalena Houdová Megová; Petr Bušek; Jana Křížová; Lucie Zdražilová; Hana Hansíková; Erik Vlčák; Vlada Filimonenko; Aleksi Šedo; Karel Smetana; Milan Jakubek
Journal:  Pharmaceutics       Date:  2022-08-17       Impact factor: 6.525

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.